U.S. markets open in 4 hours 48 minutes

Trevena, Inc. (TRVN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.1545-0.0105 (-6.36%)
At close: 04:00PM EDT
0.1700 +0.02 (+10.03%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close0.1650
Bid0.0000 x 800
Ask0.0000 x 800
Day's Range0.1530 - 0.1694
52 Week Range0.1530 - 1.3250
Avg. Volume992,100
Market Cap26.834M
Beta (5Y Monthly)1.76
PE Ratio (TTM)N/A
EPS (TTM)-0.3530
Earnings DateNov 14, 2022 - Nov 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for TRVN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Trevena, Inc.
    Daily – Vickers Top Buyers & Sellers for 06/29/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    last yearArgus Research
View more
  • GlobeNewswire

    Trevena to Participate at the H.C. Wainwright Annual Global Investment Conference

    CHESTERBROOK, Pa., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced the Company will present a corporate overview at the H.C. Wainwright Annual Global Investment Conference being held in-person and virtually September 12- 14, 2022, in New York. Presentation DetailsDate: Monday, September 12, 2022Time: 4:30pm ETWeb

  • Zacks

    What Makes Trevena (TRVN) a New Buy Stock

    Trevena (TRVN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • Simply Wall St.

    We're A Little Worried About Trevena's (NASDAQ:TRVN) Cash Burn Rate

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...